This application seeks approval for a “β-Galactosidase (EC 3.2.1.23)' enzyme derived from a genetically modified organism for use as a processing aid in dairy food applications.

The purpose of this application is to amend the Food Standards Code to permit the
use of nicotinamide riboside chloride as a permitted form of Vitamin B3 in food
for special medical purposes (FSMPs).

This application sought approval to permit the sale of low-THC hemp leaf, seed sprout and root as food and food ingredients in Australia and New Zealand. It was withdrawn.
 

This application seeks approval to permit the use of a steviol glycoside mixture, Rebaudioside MD, that is produced by fermentation from a genetically modified Yarrowia lipolytica (Y. lipolytica), expressing steviol glycoside biosynthesis pathway genes, as an intense sweetener.

The purpose of the application is to extend the option of phytosanitary irradiation to all types of fresh fruits and vegetables.

Approval Report - 12 May 2021(PDF 456 kb) (Word 238 kb)

The purpose of this application is to permit the use of subtilisin from a genetically modified strain of
Bacillus licheniformis containing the subtilisin gene from
Pyrococcus furiosus, as a processing aid in the production of potable alcohol.